2025 MSK Department of Pathology and Laboratory Medicine Alumni Meeting

In its 49th year, MSK’s Department of Pathology and Laboratory Medicine Alumni Meeting will feature engaging case presentations designed to foster meaningful discussions on the identification and diagnosis of disease. Attendees will also gain deeper biological insights into rare cancer types. This year’s meeting will be a one-day hybrid event, with the option to attend either in person or virtually.

The program will also include the presentation of the Fred W. Stewart Award of Memorial Sloan Kettering Cancer Center. This annual award honors a pathologist whose contributions have significantly advanced our understanding of human cancer, with particular emphasis on clinical impact in diagnosis and patient care. The award reflects the traditions and values brought to the Department of Pathology by Dr. Stewart, who served first as an associate of Dr. James Ewing and later as Chairman of the Department for more than 30 years.

This year’s award recipient is Dr. Esther Oliva, Professor of Pathology at Harvard Medical School and Director of Gynecologic Pathology at Massachusetts General Hospital. Dr. Esther is an internationally recognized expert and frequent invited speaker across the United States and abroad.

She serves on the editorial boards of numerous journals, including The American Journal of Surgical Pathology, Archives of Pathology and Laboratory Medicine, Human Pathology, International Journal of Gynecologic Pathology, Advances in Anatomic Pathology, Modern Pathology, Seminars in Diagnostic Pathology, and Pathology (Australia).

She is the current Secretary of the International Society of Gynecological Pathology. Dr. Esther has published more than 150 peer-reviewed articles, is co-editor of Gynecologic Pathology (Foundations in Diagnostic Pathology series), editor of Current Concepts in Gynecologic Pathology: Mesenchymal Tumors of the Female Genital Tract, and co-editor of Diagnostic Pathology: Gynecologic (Amirsys). She also contributed extensively to the most recent WHO Classification of Tumors of the Female Genital Tract.

Her research focuses primarily on neoplastic diseases of the female genital tract—particularly mesenchymal tumors—at morphologic, translational, and molecular levels, as well as on diseases of the genitourinary tract.

1. Identify pathological features of various cancer types
2. Describe ancillary techniques and markers which aid in diagnoses
3. Discuss differential diagnoses and pertinent scientific literature

This program is open exclusively to alumni of the MSK Department of Pathology and Laboratory Medicine. Participants may choose to attend either in person or virtually. Please note that the dinner will be available to in-person guests only. In-person participants should contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations for joining us onsite.

Registration Fees

• Course Registration Fee (In-Person or Virtual): $100

• Dinner at Riverpark, NYC (In-Person Guests Only):

  • Dinner for One: $125

  • Dinner for Two: $250

Registration is complimentary for MSK employees. Sign in to the MSK CME Portal using your SSO credentials.

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Please note that "Industry Professionals" are welcome to attend Continuing Medical Education events at Memorial Sloan Kettering Cancer Center for their own educational purposes. View our Registration Policy for Industry Professionals for more information.

For details on our cancellation terms, please review our Cancellation Policy.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Hotel Accommodations

We look forward to welcoming you to Memorial Sloan Kettering for this program. If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, Memorial Sloan Kettering has negotiated special rates and amenities at select hotels in Manhattan. To view the list of select hotels and additional details on each, please visit: msk.org/accommodations

Parking Information

Street parking in Manhattan is extremely limited, so you may find it more convenient to park in Memorial Sloan Kettering’s garage or in a commercial garage. For a list of parking resources around MSK, click here. Please note that MSK CME does not offer parking validation for Symposium attendees.

MSK Course Director

Meera R. Hameed, MD
Chief, Surgical Pathology Service 
Department of Pathology and Laboratory Medicine 

MSK Course Co-Directors

Lora Hedrick Ellenson, MD
Director, Gynecologic Pathology
Vice Chair of Faculty and Academic Affairs
Attending, Surgical and Gynecologic Pathology
Department of Pathology and Laboratory Medicine 

Fresia Pareja, MD, PhD
Assistant Attending, Breast Pathology
Department of Pathology and Laboratory Medicine 

Hong (Amy) Zhang, MD, PhD
Associate Attending, Breast Pathology
Department of Pathology and Laboratory Medicine 

MSK Leadership Welcome 

Kojo S. J. Elenitoba-Johnson, MD
Chairman Attending
Department of Pathology and Laboratory Medicine

Fred W. Steward Awardee & Lecturer 

Esther Oliva, MD
Professor of Pathology, Harvard Medical School
Director of Gynecologic Pathology, Massachusetts General Hospital

MSK Case Presenters

Joyce Chen, MD, PhD
Assistant Attending Pathologist

June Chan, PhD
Assistant Attending Microbiologist

Sarah Chiang, MD
Associate Attending Pathologist

M. Herman Chui, MD, FRCPC
Assistant Attending Pathologist

M. Gabriela Kuba, MD
Assistant Attending Pathologist

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.